Cannabidiol modulates exosomal miRNA networks to enhance Imatinib mesylate response in chronic myelogenous leukemia
Background/Objectives: Chronic myelogenous leukemia (CML) is a clonal myeloproliferative disease driven by the BCR-ABL1 fusion oncogene. Tyrosine kinase inhibitors (TKIs) such as Imatinib mesylate have dramatically improved patient outcomes, yet resistance remains a major obstacle to long-term effic...
Kaydedildi:
| Asıl Yazarlar: | , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
KeAi Communications Co., Ltd.
2026-03-01
|
| Seri Bilgileri: | Global Medical Genetics |
| Konular: | |
| Online Erişim: | http://www.sciencedirect.com/science/article/pii/S2699940426000020 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|